Angiotensin receptor blocker/Calcium antagonist combination therapy on diurnal blood pressure variation
Phase of Trial: Phase IV
Latest Information Update: 31 May 2017
Price : $35 *
At a glance
- Drugs Amlodipine/irbesartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 30 May 2017 Status changed from recruiting to completed.
- 04 Feb 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 10 Mar 2014 New trial record